Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
New Retina Radio by Eyetube
Retina Today
218 episodes
3 days ago
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
RSS
All content for New Retina Radio by Eyetube is the property of Retina Today and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders
New Retina Radio by Eyetube
23 minutes
2 months ago
ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders
Time flies: Some wet AMD patients have had the Port Delivery System with Ranibizumab (Susvimo, Genentech/Roche) for more than 5 years. How well does vision hold up at 5 years? And how do those numbers compare to 5-year endpoints in injection-based studies? John Kitchens, MD, reviews the dynamics around the PORTAL study, which assessed outcomes after 5 years of PDS treatment. And Krishna Mukkamala, MD, reviews data from a first-ever study validating longitudinal performance of AI-based home OCT (Scanly Home OCT, Notal Vision) compared with human experts. Just how sensitive and specific was home OCT compared with human graders? 
New Retina Radio by Eyetube
New Retina Radio is a place to hear stories about retina that are told nowhere else.